Innate Pharma S.A. earnings per share and revenue

IPHA earnings per share for the last semiannual are -0.35 USD whereas the estimation was -0.27 USD which accounts for -29.53% surprise. Company revenue for the same period amounts to 8.67 M USD despite the estimated figure of 18.24 M USD. Estimated earnings per share for the next semiannual are -0.37 USD, and revenue is expected to reach 10.10 M USD. Also watch annual changes over time to get a bigger picture of IPHA earnings per share and revenue dynamics.